Security Analysis: Examining Chainlink's "Non-Toxic MEV" Classification

Throughout this discussion, Chainlink and advocates have used the term “non-toxic MEV” to describe Atlas’s liquidation protection. As a security researcher, I want to rigorously examine this classification and whether it’s technically accurate or just effective marketing.

Defining the Taxonomy

From an academic and security standpoint, MEV classification matters for risk assessment:

Toxic MEV

Definition: Value extraction that harms user outcomes and provides no system benefit

Examples:

  • Sandwich attacks: Frontrun user swap, move price up, backrun to profit (user loses value)
  • Frontrunning: See user transaction, submit same transaction with higher gas (user’s intended action stolen)
  • NFT sniping: Frontrun NFT mint/purchase (user pays more or loses opportunity)

Characteristics:

  • User intended outcome ≠ actual outcome
  • Pure rent-seeking
  • Zero-sum extraction (MEV bot gain = user loss)
  • No benefit to protocol or system stability

Non-Toxic MEV

Definition: Value extraction that is necessary for system integrity or provides public good

Examples:

  • Liquidation backrunning: Ensuring undercollateralized positions get closed (prevents protocol insolvency)
  • Arbitrage: Price discrepancies corrected across venues (improves market efficiency)
  • Backrunning oracle updates: Fast execution of state changes based on new information

Characteristics:

  • Outcome would occur regardless (liquidation must happen)
  • System benefits from speed/efficiency
  • Positive-sum in aggregate (protocol stays solvent)
  • User already in predetermined state (e.g., liquidation threshold crossed)

Is Chainlink Atlas Actually “Non-Toxic”?

Based on technical architecture review, yes—the classification is accurate.

Why Atlas Qualifies as Non-Toxic

  1. Liquidations are protocol-mandated events: When a user’s collateral ratio falls below threshold, liquidation MUST occur for protocol health. This isn’t optional or user-harming—it’s the protocol working as designed.

  2. Atlas cannot be used for toxic MEV: The dual aggregator architecture restricts functionality to backrunning oracle updates for liquidations. It cannot frontrun user transactions, sandwich DEX swaps, or engage in predatory MEV.

  3. Value recapture benefits protocol/users: The 65% protocol share from MEV recapture funds protocol development, reduces fees, or compensates liquidity providers. Unlike pure extraction, this has positive externalities.

  4. Searcher competition improves execution: The auction mechanism ensures liquidations execute quickly and efficiently, which prevents cascading failures during volatile markets.

The Counterargument: “It’s Still Extraction”

Some argue that any MEV is extraction, regardless of necessity. Let me address this:

Claim: “Users getting liquidated still lose money, so calling it ‘non-toxic’ is just PR.”

Response: The user is liquidated because they failed to maintain sufficient collateral. The liquidation would happen regardless of whether MEV exists. Atlas doesn’t change the user outcome—it changes who profits (protocol vs. anonymous bots).

Claim: “Searchers still keep 60% of the value, so most MEV still leaks.”

Response: Searchers have real costs (gas, infrastructure, risk). The 40% recaptured represents a massive improvement over 0%. Perfect isn’t the enemy of good.

Claim: “Calling it ‘non-toxic’ makes people think it’s not value extraction.”

Response: This is a fair critique. Better terminology might be:

  • “Necessary MEV” (emphasizes system requirement)
  • “Protocol-beneficial MEV” (emphasizes positive use of extracted value)
  • “Liquidation efficiency capture” (more descriptive, less loaded)

The Real Security Concern: Centralization

While “non-toxic” is technically accurate, the centralization risk from Atlas is toxic to decentralization.

Single Provider Risk

Atlas as currently deployed:

  • Chainlink exclusive (RedStone deprecated)
  • No multi-provider competition
  • Protocols economically forced to integrate
  • Single point of failure across 5+ chains

This creates security risks that may outweigh MEV benefits:

  1. Downtime during volatility: If Atlas fails during market crash, liquidations fail → protocol insolvency
  2. Censorship risk: Single provider can theoretically censor specific users/protocols
  3. Pricing power: Monopoly position allows fee increases once protocols are locked in
  4. Cross-chain contagion: Failure on one chain cascades to all chains

Historical example: March 2020 “Black Thursday”

  • MakerDAO liquidation system failed due to network congestion
  • $8.32M in DAI liquidated at $0 (failed auctions)
  • Protocol lost more from failed liquidations than it would have lost to MEV

If Atlas had existed and also failed, the outcome would have been the same—or worse if protocols had disabled fallback mechanisms in favor of Atlas-only liquidation.

Recommendations

For Protocols

  1. Maintain fallback liquidation logic that works without Atlas
  2. Test Atlas failure scenarios under stress conditions
  3. Monitor Atlas uptime and have circuit breakers for anomalies
  4. Diversify MEV protection if alternatives emerge

For Chainlink

  1. Publish transparent uptime SLAs per chain
  2. Open-source core auction logic for community audit
  3. Commit to decentralization roadmap (multi-provider model)
  4. Emergency pause mechanisms if anomalies detected

For the Community

  1. Develop open MEV protection standards (Brian’s ERC proposal)
  2. Grant programs for smaller protocols (democratize access)
  3. Independent monitoring of Atlas performance (Mike’s dashboard)
  4. Alternative implementations to create competitive pressure

My Verdict

“Non-toxic MEV” is technically accurate for describing liquidation backrunning. Liquidations are necessary, Atlas improves efficiency, and recaptured value benefits protocols.

But calling something “non-toxic” doesn’t make it risk-free. The centralization introduced by Atlas creates systemic risks that must be actively managed.

The label is correct. The implementation needs safeguards.

Security is not a feature, it’s a process. :locked: Trust but verify—then verify again.


Sources:

Sophia’s technical taxonomy is spot-on. Let me add architectural context.

Why Atlas Architecture Enforces “Non-Toxic” Classification

The dual aggregator design makes toxic MEV structurally impossible:

Standard oracle update (public):
→ Anyone can see and frontrun
→ Enables sandwich attacks, frontrunning, etc.

SVR-enhanced update (private window):
→ Oracle update goes to auction first
→ Searchers bid for backrun rights AFTER update
→ No mempool visibility = no frontrunning opportunity

This isn’t just policy (“please don’t use this for toxic MEV”)—it’s architectural enforcement. The system physically cannot be used for sandwich attacks because user transactions aren’t in the auction flow.

Comparison to PBS (Proposer-Builder Separation)

Ethereum’s PBS faces similar “is this toxic?” questions:

PBS benefits:

  • Separates validation from block building (decentralization)
  • MEV-Boost recaptures value for validators/network
  • Improves block efficiency

PBS concerns:

  • 90% of blocks through centralized relays
  • Builders can censor transactions
  • Value extraction still occurs (just redistributed)

Sound familiar? Atlas has the same trade-off profile.

My take: Both PBS and Atlas are “non-toxic” in that they improve on the alternative (pure extractive MEV), but both introduce centralization risks that need ongoing mitigation.

The Terminology Problem

Sophia’s suggestion for better terms is excellent:

  • “Necessary MEV” ✓
  • “Protocol-beneficial MEV” ✓
  • “Liquidation efficiency capture” ✓

“Non-toxic” sounds like “harmless,” which isn’t quite right. It’s more accurate to say: “This MEV extraction is a lesser evil than the alternative, and the recaptured value benefits the system.”

That’s a mouthful, but it’s honest.

What Would Make Atlas “Genuinely Non-Toxic”?

  1. Open-source auction mechanism → Anyone can verify no hidden extraction
  2. Multi-provider competition → Prevents monopoly pricing power
  3. Protocol-level integration → Built into Ethereum base layer, not application layer
  4. Decentralized node operators → No single entity controls ordering

Chainlink is 1-2 steps on this path. We need to push for the rest.

From a protocol operator perspective, “non-toxic” matters because it changes how I think about integration.

If Atlas were toxic MEV (sandwich attacks, frontrunning):
→ I wouldn’t integrate it
→ Would harm our users
→ Reputation risk outweighs profit

Because Atlas is non-toxic (liquidation efficiency):
→ Integration makes sense
→ Liquidations happen regardless; recapturing value is pure upside
→ Users benefit indirectly through protocol treasury funding

Sophia’s point about terminology is important for user communication. When I pitch Atlas integration to our community, I say:

“We’re implementing a system that captures value during liquidations that would otherwise go to bots, and returns it to the protocol treasury to fund development and reduce fees.”

NOT:

“We’re recapturing non-toxic MEV.” (Too technical, sounds sketchy)

The Transparent Extraction Argument

I actually prefer transparent extraction (Atlas) over hidden extraction (anonymous MEV bots).

Before Atlas:

  • Bots extract 100% of liquidation value
  • Protocol/users get 0%
  • No visibility into who profits

With Atlas:

  • Auction extracts ~40% of value
  • Protocol gets 65% of that (26% of total)
  • Chainlink gets 35% (14% of total)
  • Remaining ~60% goes to searchers
  • ALL of this is visible on-chain

Even though extraction still occurs, at least we know:

  • Who’s extracting
  • How much they’re taking
  • Where the money goes

That transparency creates accountability. If Chainlink changes fee splits unfavorably, the community can see it immediately and react.

So yes, “non-toxic” is accurate, but “transparent” is the feature I value most.

Sophia’s academic rigor + Diana’s operational perspective = the perfect combo for understanding this.

Let me propose data-driven metrics to track whether “non-toxic” remains accurate over time.

Measurable Criteria for “Non-Toxic” MEV

1. Value distribution transparency:

  • Protocol share: Should be ≥60% (currently 65%)
  • Chainlink share: Should be ≤40% (currently 35%)
  • If this flips, it becomes more extractive

2. User outcome independence:

  • Liquidation outcome WITH Atlas = same as WITHOUT Atlas
  • Only difference: who captures profit
  • If Atlas changes liquidation thresholds/penalties to increase MEV, that’s toxic

3. System health improvement:

  • Liquidation execution speed: Should be faster with Atlas
  • Failed liquidation rate: Should be lower
  • Protocol solvency: Should improve (recaptured funds reinvested)

4. Accessibility:

  • Number of protocols with access: Should increase over time
  • Pricing tiers: Should become more accessible
  • If Atlas becomes exclusive to top 10 protocols, that’s extractive gate-keeping

Tracking These Metrics

My proposed MEV transparency dashboard would track all of this:

Real-time:

  • Current fee splits (protocol/Chainlink/searcher)
  • Liquidation execution performance
  • Failed liquidation rate

Historical trends:

  • Fee split changes over time
  • Protocol adoption growth
  • Recapture rate by chain/protocol

Red flags:

  • Chainlink increases its share above 40%
  • Liquidation mechanics change to increase MEV opportunity
  • Accessibility decreases (fewer protocols can afford it)

If we see these red flags, “non-toxic” becomes questionable.

Data Makes it Objective

Right now “non-toxic” is a qualitative label. Let’s make it quantitative:

Non-toxic = ✓ if:

  • Protocol share ≥ 60%
  • User outcomes unchanged
  • System health improved
  • Accessibility increasing

Becomes toxic = ✗ if:

  • Fee split favors Chainlink
  • Liquidations modified to extract more
  • Only top protocols have access

I’ll build this dashboard to keep everyone honest.

Sophia, this analysis finally makes sense to me. Thank you for breaking it down.

My New Understanding

Toxic MEV (bad): Bot sees my transaction, frontrunsbetter, I get worse price than expected

  • Example: I try to buy a token, bot sandwich attacks me, I pay 5% more

Non-toxic MEV (necessary): My collateral drops below threshold, liquidation must happen

  • Example: I borrowed against ETH, ETH price crashes, I get liquidated
  • Atlas doesn’t change that I get liquidated—it changes who profits from executing it

That distinction makes sense now.

How I’ll Explain to Users

In our UI, I’ll add tooltips like:

“MEV Protection Active”
This protocol uses Chainlink Atlas to ensure that when liquidations occur, the protocol recaptures value that would otherwise go to bots. This doesn’t prevent liquidations—it helps the protocol fund security and development.

Not: “Non-toxic MEV recapture” (too jargony)

My Remaining Question

Sophia mentioned users are “already in predetermined state” when liquidations happen. But from a UX perspective, users often don’t realize they’re close to liquidation.

Better user protection would be:

  • Real-time health factor warnings
  • Push notifications before liquidation
  • Auto-rebalancing options

Atlas helps AFTER someone gets liquidated. But preventing liquidations in the first place would be better for users.

Is there any MEV protection that helps users avoid getting into liquidation situations, rather than just recapturing value after it happens?